Country |
New clients reported |
Population (15 to 64) in 2005 |
Reported incidence per 100000 population | |
|---|---|---|---|---|
Belgium |
(1) |
4826 |
6818862 |
70.8 |
Czech Republic |
|
4600 |
7259001 |
63.4 |
Denmark |
|
1696 |
3580756 |
47.4 |
Germany |
|
13204 |
55208740 |
23.9 |
Greece |
(1) |
2162 |
7470657 |
28.9 |
Spain |
(2) |
17228 |
29569109 |
58.3 |
France |
(3) |
7208 |
39438149 |
18.3 |
Ireland |
(4) |
2178 |
2800071 |
77.8 |
Italy |
|
34308 |
38569415 |
89.0 |
Cyprus |
|
227 |
515997 |
44.0 |
Latvia |
|
438 |
1583843 |
27.7 |
Lithuania |
|
425 |
2323163 |
18.3 |
Hungary |
|
5655 |
6940253 |
81.5 |
Malta |
|
167 |
278039 |
60.1 |
Netherlands |
|
4785 |
11008282 |
43.5 |
Austria |
|
847 |
5572238 |
15.2 |
Poland |
(2) |
6697 |
26778325 |
25.0 |
Portugal |
|
5023 |
7091279 |
70.8 |
Slovenia |
|
526 |
1404428 |
37.5 |
Slovakia |
|
1045 |
3839969 |
27.2 |
Finland |
|
735 |
3491111 |
21.1 |
Sweden |
(5) |
1417 |
5873476 |
24.1 |
United Kingdom |
(1) |
29865 |
39279725 |
76.0 |
Bulgaria |
|
667 |
5357021 |
12.5 |
Romania |
|
710 |
15046735 |
4.7 |
|
|
|
|
|
Total |
|
146639 |
327098644 |
44.8 |
Notes: Only countries that sent information about first treatments are included. (1) Population data refer to 2004. (2) For drug clients 2003 data are reported. (3) 1999 data for drug clients are reported; 2004 population data are reported. (4) For drug clients 2002 data are reported. (5) Coverage of treatment units is partial and under development. See also 'General notes for interpreting data' on the Explanatory notes and help page. Source: 2005 Reitox national reports - ST03 - For total number of clients see Table TDI-2. For population see EUROSTAT - Demographic data 2005 | ||||